| Name | Title | Contact Details |
|---|
Squirrel Systems of Canada is a Burnaby, BC-based company in the Software & Internet sector.
Blue Moon Industries is a Providence, RI-based company in the Software and Internet sector.
Oden Industries Inc is a San Bernardino, CA-based company in the Software and Internet sector.
We are a knowledgeable team that enjoys working with industry leaders and those just beginning their sustainability journeys. Our sustainability management software, Optera, enables companies to track, manage and achieve goals in a platform designed and supported by sustainability experts. The Optera platform is born from 20+ years of work with leading companies and NGOs. Since 2006, our team has provided leading corporations with innovative solutions to lower costs and accelerate progress toward their climate and sustainability goals. Our research of the business case for climate action helped to launch science-based emissions targets, found in publications such as: The 3% Solution, The Climate Has Changed, Green Giants, Reinventing Fire, and New Climate Economy Our experienced team has assisted global market leaders, technology startups, NGOs, and highly respected utilities and communities to advance sustainability and climate goals.
Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing. The proprietary, automated genomic interpretation platform allows clinical laboratories to tune Cypher Genomics' market leading sensitivity and specificity profiles to develop molecular tests for diagnostic and prognostic use, and pharmaceutical companies to discover biomarkers from whole genome sequence data in sample sizes typical of early stage drug development studies. Through Mantis™, the genome interpretation software as a service offering, and Coral™, a biomarker discovery service, Cypher Genomics can improve health care and reduce costs by facilitating improved diagnostic accuracy and earlier interventions, optimizing therapeutic approaches and reducing adverse drug reactions. The gap between the ability to generate whole genome sequences at scale and the primarily manual process of interpretation to date creates a significant unmet need that is well served by the Cypher Genomics solution.